Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1984-12-06
1986-07-22
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
106210, 424 19, 424 22, 514165, 514778, A61K 922, A61K 3160, A61K 4700
Patent
active
046018956
ABSTRACT:
A delayed-action acetylsalicylic acid formulation comprising by weight 60 to 90% of acetylsalicylic acid, 8 to 40% pregelatinized starch, and 0 to 30% of additives. The amount of starch controls the rate of release.
REFERENCES:
patent: 3034911 (1982-05-01), McKee et al.
patent: 3101299 (1963-08-01), Ferrand
patent: 3490742 (1970-01-01), Nichols et al.
patent: 3622677 (1971-11-01), Short et al.
patent: 3725556 (1973-04-01), Hanssen et al.
patent: 3946110 (1976-03-01), Hill
patent: 4072535 (1978-02-01), Short et al.
patent: 4086335 (1978-04-01), Bruscato et al.
patent: 4198507 (1980-04-01), Barry et al.
patent: 4264573 (1981-04-01), Powell et al.
patent: 4308251 (1981-12-01), Dunn et al.
patent: 4328217 (1982-05-01), Gabby et al.
patent: 4339428 (1982-07-01), Tencza
patent: 4361545 (1982-11-01), Powell et al.
patent: 4369308 (1983-01-01), Trubiano
patent: 4375468 (1983-03-01), Dunn
patent: 4401665 (1983-08-01), Sheinaus et al.
patent: 4439453 (1984-03-01), Vogel
patent: 4520009 (1985-05-01), Dunn
patent: 4525345 (1985-06-01), Dunn et al.
patent: 4539198 (1985-09-01), Powell et al.
patent: 4551177 (1985-11-01), Trubiano et al.
Putter, deceased Johann
Streuff Bernhard
Bayer Aktiengesellschaft
Rose Shep K.
LandOfFree
Delayed-action acetylsalicylic acid formulations for oral admini does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delayed-action acetylsalicylic acid formulations for oral admini, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delayed-action acetylsalicylic acid formulations for oral admini will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-865357